EUVIMEDEUVIMED entdecken
Crossref

Epitope-Optimized Influenza Hemagglutinin Nanoparticle Vaccine Provides Broad Cross-Reactive Immunity against H9N2 Influenza Virus

Mengchan Hao, Yanhai Wang, Wenxue Yang, Meng Xu, Yiwei Guan, Yuan Zhang, JianJun Chen iD

ACS Nano · 10.06.2025 · 19 (22) · 20824-20840

DOI: 10.1021/acsnano.5c03199 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 02.06.2025. Verfasst von Mengchan Hao und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, People's Republic of China. Hauptthemen laut MEDLINE: Influenza A Virus, H9N2 Subtype, Influenza Vaccines, Nanoparticles, Epitopes. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Major Project of Guangzhou National Laboratory.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza A Virus, H9N2 SubtypeInfluenza VaccinesNanoparticlesEpitopesHemagglutinin Glycoproteins, Influenza VirusAnimalsCross ReactionsMiceHumansMice, Inbred BALB COrthomyxoviridae InfectionsFemaleAntibodies, ViralNanovaccines

Stichwörter der Autor:innen

H9N2 influenza viruscellular immunitycross-reactivityepigraphhumoral immunitynanoparticlesuniversal vaccine

Substanzen

Influenza VaccinesEpitopesHemagglutinin Glycoproteins, Influenza VirusAntibodies, ViralNanovaccines

Autor:innen und Institutionen

  • State Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, People's Republic of China.
  • University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China.

ORCID-Profile: JianJun Chen

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Major Project of Guangzhou National Laboratory

Zitieren

APA

Hao, M., Wang, Y., Yang, W., Xu, M., Guan, Y., Zhang, Y., & Chen, J. (2025). Epitope-Optimized Influenza Hemagglutinin Nanoparticle Vaccine Provides Broad Cross-Reactive Immunity against H9N2 Influenza Virus. ACS Nano, 19(22), 20824-20840. https://doi.org/10.1021/acsnano.5c03199

Vancouver

Hao M, Wang Y, Yang W, Xu M, Guan Y, Zhang Y, et al. Epitope-Optimized Influenza Hemagglutinin Nanoparticle Vaccine Provides Broad Cross-Reactive Immunity against H9N2 Influenza Virus. ACS Nano. 2025;19(22):20824-20840. doi:10.1021/acsnano.5c03199

BibTeX
@article{Hao2025,
  author = {Hao, Mengchan and Wang, Yanhai and Yang, Wenxue and Xu, Meng and Guan, Yiwei and Zhang, Yuan and Chen, JianJun},
  title = {Epitope-Optimized Influenza Hemagglutinin Nanoparticle Vaccine Provides Broad Cross-Reactive Immunity against H9N2 Influenza Virus},
  journal = {ACS Nano},
  year = {2025},
  volume = {19},
  number = {22},
  pages = {20824--20840},
  doi = {10.1021/acsnano.5c03199}
}
Kostenlos starten →